On July 15, Merck fell 3.03% in regular trading, trading at $120.42 USD/share, with Turnover of $3.82 billion.
Within the Pharmacy sector where Merck belongs, the overall sector is under broad pressure. Among individual stocks, Eli Lilly down 2.19%, Johnson & Johnson down 1.78%, Pfizer down 1.02%, AstraZeneca PLC down 1.91%, Bristol-Myers Squibb down 1.99%.
Merck & Co., Inc. operates as a global healthcare company through its Pharmaceutical and Animal Health segments, offering products in oncology, immunology, virology, cardiovascular, and diabetes areas under brands including Keytruda, as well as vaccine products such as Gardasil and preventive pediatric and adult vaccines.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)